<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">Antimicrob Agents Chemother</span><span class="iso-abbrev" title="iso-abbrev">Antimicrob Agents Chemother</span><span class="hwp" title="hwp">aac</span><span class="pmc" title="pmc">aac</span><span class="publisher-id" title="publisher-id">AAC</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Antimicrobial Agents and Chemotherapy</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">0066-4804</span><span class="issn-epub" tagx="issn" title="issn-epub">1098-6596</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">American Society for Microbiology</span><span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">1752 N St., N.W., Washington, DC</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7848973">7848973</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/33257443">33257443</a></span><span class="publisher-id" title="publisher-id">01995-20</span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1128/AAC.01995-20">10.1128/AAC.01995-20</a></span><div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Pharmacology</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title"><i>In Vivo</i> Efficacy and Metabolism of the Antimalarial Cycleanine and Improved <i>In Vitro</i> Antiplasmodial Activity of Semisynthetic Analogues</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Uche</span><span class="given-names" tagx="given-names" title="given-names">Fidelia Ijeoma</span></span><a href="#aff1"><sup>a</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">Xiaozhen</span></span><a href="#aff2"><sup>b</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Okokon</span><span class="given-names" tagx="given-names" title="given-names">Jude</span></span><a href="#aff3"><sup>c</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ullah</span><span class="given-names" tagx="given-names" title="given-names">Imran</span></span><a href="#aff4"><sup>d</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Horrocks</span><span class="given-names" tagx="given-names" title="given-names">Paul</span></span><a href="#aff4"><sup>d</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Boateng</span><span class="given-names" tagx="given-names" title="given-names">Joshua</span></span><a href="#aff5"><sup>e</sup></a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Chenggang</span></span><a href="#aff2"><sup>b</sup></a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-3706-6068</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Wen-Wu</span></span><a href="#aff1"><sup>a</sup></a></span><span class="citation_author_institution" id="aff1">[a], <span class="addr-line" title="addr-line">School of Pharmacy and Bioengineering, Keele University, Stoke-on-Trent, United Kingdom</span></span><span class="citation_author_institution" id="aff2">[b], <span class="addr-line" title="addr-line">Shanghai Institute of Materia Medica, Chinese Academy of Science, Shanghai, China</span></span><span class="citation_author_institution" id="aff3">[c], <span class="addr-line" title="addr-line">Department of Pharmacology and Toxicology, Faculty of Pharmacy, University of Uyo, Uyo, Nigeria</span></span><span class="citation_author_institution" id="aff4">[d], <span class="addr-line" title="addr-line">School of Medicine, Keele University, Stoke-on-Trent, United Kingdom</span></span><span class="citation_author_institution" id="aff5">[e], <span class="addr-line" title="addr-line">School of Science, University of Greenwich, United Kingdom</span></span></div> <div class="author-notes" title="author-notes"> <div class="corresp" title="corresp">
Address correspondence to Chenggang Huang, <span class="email" tagx="email" title="email">cghuang@simm.ac.cn</span>, or Wen-Wu Li, <span class="email" tagx="email" title="email">w.li@keele.ac.uk</span>.</div> <div class="fn-type-other" title="other"> <p><b>Citation</b> Uche FI, Guo X, Okokon J, Ullah I, Horrocks P, Boateng J, Huang C, Li W-W. 2021. <i>In vivo</i> efficacy and metabolism of the antimalarial cycleanine and improved <i>in vitro</i> antiplasmodial activity of semisynthetic analogues. Antimicrob Agents Chemother 65:e01995-20. <a href="https://doi.org/10.1128/AAC.01995-20">https://doi.org/10.1128/AAC.01995-20</a>.</p> </div> </div><span class="pub-date-epreprint" title="pub-date-epreprint">epreprint: <span>2020-11-11</span></span><span class="pub-date-epub" title="pub-date-epub">epub: <span>2021-1-1</span></span><span class="pub-date-collection" title="pub-date-collection">collection: <span>2021-2</span></span><span class="pub-date-pmc-release" title="pub-date-pmc-release">pmc-release: <span>2021-1-1</span></span><span class="volume" tagx="volume" title="volume">65</span><span class="issue" tagx="issue" title="issue">2</span><span class="elocation-id" tagx="elocation-id" title="elocation-id">e01995-20</span><span class="history" title="history"><span class="received" title="received">received: 2020-9-16</span><span class="rev-request" title="rev-request">rev-request: 2020-10-9</span><span class="accepted" title="accepted">accepted: 2020-11-13</span></span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">Uche et al.</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2021</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an open-access article distributed under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</a>.</span></span></div><a class="self-uri" href="AAC.01995-20.pdf" title="self-uri">AAC.01995-20.pdf</a><div class="abstract" title="abstract"> <p>Bisbenzylisoquinoline (BBIQ) alkaloids are a diverse group of natural products that demonstrate a range of biological activities. In this study, the <i>in vitro</i> antiplasmodial activity of three BBIQ alkaloids (cycleanine [compound 1], isochondodendrine [compound 2], and 2â€²-norcocsuline [compound 3]) isolated from the <span class="named-content" title="named-content">Triclisia subcordata</span> Oliv. medicinal plant traditionally used for the treatment of malaria in Nigeria are studied alongside two semisynthetic analogues (compounds 4 and 5) of cycleanine.</p> </div> <div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
ABSTRACT</div> <p>Bisbenzylisoquinoline (BBIQ) alkaloids are a diverse group of natural products that demonstrate a range of biological activities. In this study, the <i>in vitro</i> antiplasmodial activity of three BBIQ alkaloids (cycleanine [compound 1], isochondodendrine [compound 2], and 2â€²-norcocsuline [compound 3]) isolated from the <span class="named-content" title="named-content">Triclisia subcordata</span> Oliv. medicinal plant traditionally used for the treatment of malaria in Nigeria are studied alongside two semisynthetic analogues (compounds 4 and 5) of cycleanine. The antiproliferative effects against a chloroquine-resistant <span class="named-content" title="named-content">Plasmodium falciparum</span> strain were determined using a SYBR green 1 fluorescence assay. The <i>in vivo</i> antimalarial activity of cycleanine is then investigated in suppressive, prophylactic, and curative murine malaria models after infection with a chloroquine-sensitive <span class="named-content" title="named-content">Plasmodium berghei</span> strain. BBIQ alkaloids (compounds 1 to 5) exerted <i>in vitro</i> antiplasmodial activities with 50% inhibitory concentration (IC<sub>50</sub>) at low micromolar concentrations and the two semisynthetic cycleanine analogues showed an improved potency and selectivity compared to those of cycleanine. At oral doses of 25 and 50â€‰mg/kg body weight of infected mice, cycleanine suppressed the levels of parasitemia and increased mean survival times significantly compared to those of the control groups. The metabolites and metabolic pathways of cycleanine were also studied using high-performance liquid chromatographyâ€"electrospray ionizationâ€"tandem mass spectrometry. Twelve novel metabolites were detected in rats after intragastric administration of cycleanine. The metabolic pathways of cycleanine were demonstrated to involve hydroxylation, dehydrogenation, and demethylation. Overall, these <i>in vitro</i> and <i>in vivo</i> results provide a basis for the future evaluation of cycleanine and its analogues as leads for further development.</p> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
KEYWORDS</div> <div class="kwd" title="kwd">
malaria</div> <div class="kwd" title="kwd"><i>Plasmodium falciparum</i></div> <div class="kwd" title="kwd"><i>Plasmodium berghei</i></div> <div class="kwd" title="kwd">
bisbenzylisoquinoline alkaloids</div> <div class="kwd" title="kwd">
cycleanine</div> <div class="kwd" title="kwd">
metabolism</div> <div class="kwd" title="kwd"><i>in vivo</i> activity</div> <div class="kwd" title="kwd">
antimalarial agents</div> <div class="kwd" title="kwd">
drug metabolism</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="equation-count" title="equation-count">equation-count: </span><span class="ref-count" title="ref-count">ref-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> <div class="custom-meta-group" title="custom-meta-group"> <meta name="cover-date" value="February 2021" /> </div> </div> </div> <div class="body" title="body"> <div class="text" title="sec"> <div class="title" tagx="title" title="title">
TEXT</div> <p>In 2018, the World Health Organization (WHO) report estimated a global burden of 228 million cases accounting for 405,000 deaths (<a href="#B1">1</a>). The majority of this burden fell on the WHO Africa Region, where malaria, particularly that caused by the most virulent etiological agent <span class="named-content" title="named-content">Plasmodium falciparum</span>, exerts an immense economic impact. While malaria cases and mortality figures continue to fall (<a href="#B1">1</a>, <a href="#B2">2</a>), the development and spread of resistance to available chemotherapeutic agents poses a significant threat to malaria treatment and management (<a href="#B3">3</a>). Natural products of plant origin have traditionally provided good sources for discovery of drug leads or novel compounds in modern drug research (<a href="#B4">4</a>, <a href="#B5">5</a>). For example, artemisinin isolated from <span class="named-content" title="named-content">Artemisia annua</span>, sweet wormwood, a traditional Chinese medicine, together with a series of its semisynthetic derivatives, has become the first-line therapy for <span class="named-content" title="named-content">P. falciparum</span> malaria (<a href="#B6">6</a>, <a href="#B7">7</a>). However, due to the development of artemisinin drug resistance (<a href="#B8">8</a>), novel therapies are still urgently needed.</p> <p>Bisbenzylisoquinoline (BBIQ) alkaloids are a diverse group of natural products consisting of two benzylisoquinoline groups (<a href="#B9">9</a>). BBIQ alkaloids are primarily found in the <span class="named-content" title="named-content">Berberidaceae</span>, <span class="named-content" title="named-content">Lauraceae</span>, <span class="named-content" title="named-content">Menispermaceae</span>, and <span class="named-content" title="named-content">Ranunculaceae</span> plant families. These alkaloids possess a variety of biological activities, which include antimalarial activities (<a href="#B9">9</a>, <a href="#B10">10</a>). For example, BBIQ alkaloids isolated and identified from <span class="named-content" title="named-content">Triclisia</span> species of the <i>Menispermaceae</i> family have antiproliferative activities (<a href="#B10">10</a>). In Nigeria, the root of <span class="named-content" title="named-content">Triclisia subcordata</span> Oliv. is traditionally used for the treatment of a range of diseases, including malaria (<a href="#B11">11</a>, <a href="#B12">12</a>). The bioactive components of <span class="named-content" title="named-content">T. subcordata</span> are the BBIQ alkaloids cycleanine (compound 1), isochondodendrine (compound 2) and 2â€²-norcocsuline (compound 3) (<a href="#F1">Fig. 1</a>) and have previously been isolated and characterized by our group (<a href="#B13">13</a>, <a href="#B14">14</a>). We have also produced synthetic analogues of cycleanine (compounds 4 and 5) (<a href="#F1">Fig. 1</a>) (<a href="#B15">15</a>). The three naturally occurring BBIQ alkaloids, cycleanine (<a href="#B16">16</a><a href="#B17">â€"</a><a href="#B18">18</a>), isochondodendrine (<a href="#B18">18</a>, <a href="#B19">19</a>), and 2â€²-norcocsuline (<a href="#B16">16</a>, <a href="#B20">20</a>) have been reported to possess antiplasmodial effects against chloroquine-sensitive and chloroquine-resistant <span class="named-content" title="named-content">P. falciparum</span> strains. Despite the promising <i>in vitro</i> biological activity of these natural BBIQ alkaloids, the <i>in vivo</i> antimalarial activity of BBIQ alkaloids has not been evaluated, nor has their potential <i>in vivo</i> metabolism. Here, we assess the <i>in vivo</i> antimalarial activity and metabolism of cycleanine (compound 1). The effect of cycleanine analogues (compounds 4 and 5) on antiplasmodial potency and selectivity is also investigated.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FIG 1</span></a></div>   <p>Chemical structure of bisbenzylisoquinoline (BBIQ) alkaloids. Cycleanine (compound 1), isochondodendrine (compound 2), and 2â€²-norcocsuline (compound 3) from <span class="named-content" title="named-content">T. subcordata</span> and two novel semisynthetic analogues (compounds 4 and 5) of cycleanine.</p>   </div> <p>This study sets out an evaluation of the <i>in vitro</i> antimalarial activities of BBIQ alkaloid compounds 1 to 3 compared to those of two semisynthetic BBIQ alkaloids (compounds 4 and 5) derived by a modification of cycleanine at the C-5 position by introducing additional secondary or tertiary amine moieties in an attempt to increase potential solubility and potency (<a href="#B15">15</a>). The most abundant BBIQ alkaloid in <i>T. subcordata</i> extract is cycleanine; this was therefore used to establish <i>in vivo</i> antimalarial activity in a murine malaria model. In addition, the metabolites and metabolic pathways of cycleanine were analyzed after intragastric administration in rats to help understand how cycleanine is eliminated <i>in vivo</i> to guide future optimization of cycleanine for antimalarial development.</p> </div> <div class="results" title="results"> <div class="title" tagx="title" title="title">
RESULTS</div> <div class="thesemisyntheticderivativesofcycleaninehaveimprovedinvitroantiplasmodialactivityandselectivity." title="sec"> <div class="title" tagx="title" title="title">
The semisynthetic derivatives of cycleanine have improved <i>in vitro</i> antiplasmodial activity and selectivity.</div> <p>The <i>in vitro</i> antiplasmodial activities of the five BBIQ alkaloids (compounds 1 to 5), as well as that of a chloroquine control, were determined against intraerythrocytic stages of the <span class="named-content" title="named-content">P. falciparum</span> Dd2 chloroquine-resistant strain using a malaria SYBR green I fluorescence assay. These data are provided in <a href="#T1">Table 1</a> (see Fig. S1 in the supplemental material) as 50% inhibitory concentration (IC<sub>50</sub>) values (mean Â± standard deviation [SD] for <i>n</i>â€‰=â€‰3 independent biological repeats). While the data for chloroquine in Dd2 are comparable to those of the chloroquine-resistant strain W2, the activities of cycleanine, isochondodendrine, and 2â€²-norcocsuline are significantly lower in Dd2 than that reported in W2, and certainly lower than that in the chloroquine-sensitive strain D6. The semisynthetic products 4 and 5 are relatively more potent than compound 1 to 3 in Dd2, with the most potent, compound 4, being some 25.2-fold more potent than its natural precursor, cycleanine (compound 1).</p> <div class="table-wrap_UNKNOWN" id="T1" orientation="portrait" position="float"><span class="label" tagx="label" title="label">TABLE 1</span> <p>Cytotoxicity data for BBIQ alkaloids</p>  <div class="alternatives" title="alternatives"> <table frame="hsides" rules="groups"> <colgroup span="1"> <col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup>  <thead> <tr> <th rowspan="2" colspan="1">BBIQ alkaloid (compound no.)</th> <th colspan="3" rowspan="1">IC<sub>50</sub> (Î¼M) against <span class="named-content" title="named-content">P. falciparum</span> strain<a href="#T1F1"><sup><i>a</i></sup></a><sup>,</sup><a href="#T1F4"><sup><i>d</i></sup></a>: <hr /> </th> <th colspan="2" rowspan="1">CC<sub>50</sub> (Î¼M) against cancer cell line(s): <hr /> </th> <th colspan="2" rowspan="1">SI<a href="#T1F6"><sup><i>f</i></sup></a><hr /> </th> </tr> <tr> <th rowspan="1" colspan="1">Dd2</th> <th rowspan="1" colspan="1">W2</th> <th rowspan="1" colspan="1">D6</th> <th rowspan="1" colspan="1">KB<a href="#T1F2"><sup><i>b</i></sup></a> or HCT<a href="#T1F3"><sup><i>c</i></sup></a></th> <th rowspan="1" colspan="1">HOE<a href="#T1F5"><sup><i>e</i></sup></a></th> <th rowspan="1" colspan="1">KB/W2</th> <th rowspan="1" colspan="1">HOE/Dd2</th> </tr> </thead> <tbody> <tr> <td rowspan="1" colspan="1">Cycleanine (1)</td> <td rowspan="1" colspan="1">17.7â€‰Â±â€‰2.0</td> <td rowspan="1" colspan="1">0.25<a href="#T1F2"><sup><i>b</i></sup></a>; 4.5<a href="#T1F3"><sup><i>c</i></sup></a></td> <td rowspan="1" colspan="1">0.07<a href="#T1F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">&amp;gt;33.7<a href="#T1F2"><sup><i>b</i></sup></a>; 531 (HCT)<a href="#T1F3"><sup><i>c</i></sup></a></td> <td rowspan="1" colspan="1">35.0â€‰Â±â€‰0.1</td> <td rowspan="1" colspan="1">&amp;gt;133</td> <td rowspan="1" colspan="1">2.0</td> </tr> <tr> <td rowspan="1" colspan="1">Isochondodendrine (2)</td> <td rowspan="1" colspan="1">6.1â€‰Â±â€‰1.3</td> <td rowspan="1" colspan="1">0.2<a href="#T1F3"><sup><i>c</i></sup></a></td> <td rowspan="1" colspan="1">ND<a href="#T1F4"><sup><i>d</i></sup></a></td> <td rowspan="1" colspan="1">29 (HCT)<a href="#T1F3"><sup><i>c</i></sup></a></td> <td rowspan="1" colspan="1">10.5â€‰Â±â€‰1.2</td> <td rowspan="1" colspan="1">116</td> <td rowspan="1" colspan="1">1.7</td> </tr> <tr> <td rowspan="1" colspan="1">2â€²-Norcocsuline (3)</td> <td rowspan="1" colspan="1">7.0â€‰Â±â€‰1.6</td> <td rowspan="1" colspan="1">0.28<a href="#T1F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">0.048<a href="#T1F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">3.8<a href="#T1F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">8.0â€‰Â±â€‰0.2</td> <td rowspan="1" colspan="1">14</td> <td rowspan="1" colspan="1">1.1</td> </tr> <tr> <td rowspan="1" colspan="1">5-[(Dimethylamino)methyl]cycleanine (4)</td> <td rowspan="1" colspan="1">0.7â€‰Â±â€‰0.1</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">10.0â€‰Â±â€‰0.2</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">14.3</td> </tr> <tr> <td rowspan="1" colspan="1">5-[(Propargylamino)methyl]cycleanine (5)</td> <td rowspan="1" colspan="1">1.8â€‰Â±â€‰0.2</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">32.0â€‰Â±â€‰1.6</td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">17.8</td> </tr> <tr> <td rowspan="1" colspan="1">Chloroquine</td> <td rowspan="1" colspan="1">0.18â€‰Â±â€‰0.03</td> <td rowspan="1" colspan="1">0.135<a href="#T1F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">0.006<a href="#T1F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">33.7<a href="#T1F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">ND</td> <td rowspan="1" colspan="1">250</td> <td rowspan="1" colspan="1">ND</td> </tr> </tbody> </table> <div class="graphic" /> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">a</span><p><i>In vitro</i> 50% inhibitory concentration (IC<sub>50</sub>) values of BBIQ alkaloids (compounds 1 to 5) against <span class="named-content" title="named-content">P. falciparum</span> chloroquine-resistant strains (Dd2 and W2 strains) and the chloroquine-sensitive strain (D6). IC<sub>50</sub> values are expressed as mean Â± SD for <i>n</i>â€‰=â€‰3 independent biological repeats.</p> </div> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">b</span><p>IC<sub>50</sub> data against <span class="named-content" title="named-content">P. falciparum</span> W2 and D6 strains and 50% cytotoxic concentration (CC<sub>50</sub>) values for human oral epidermoid carcinoma (KB) cells were sourced from a previous report (<a href="#B16">16</a>).</p> </div> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">c</span><p>IC<sub>50</sub> data against chloroquine-resistant <span class="named-content" title="named-content">P. falciparum</span> strain W2 and CC<sub>50</sub> values for HCT-116 human colon carcinoma cells were sourced from a previous report (<a href="#B18">18</a>).</p> </div> <div class="fn-type-abbr" title="abbr"><span class="label" tagx="label" title="label">d</span><p>ND, not determined.</p> </div> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">e</span><p>CC<sub>50</sub> data for human ovarian epithelial (HOE) cells. Data in this column for compounds 1 to 5 were sourced from our previous reports (<a href="#B13">13</a>, <a href="#B15">15</a>).</p> </div> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">f</span><p>This selectivity index (SI) was calculated as CC<sub>50</sub> /IC<sub>50</sub> against <span class="named-content" title="named-content">P. falciparum</span>.</p> </div> </div> </div> <p>Data from cytotoxicity studies of BBIQ alkaloids 1 to 3 in human oral epidermoid carcinoma (KB) or HCT-116 human colon carcinoma cells suggest low to moderate selectivity, with a selectivity index (SI) of 14 to &amp;gt;133. Fifty percent cytotoxic concentration (CC<sub>50</sub>) data for all five compounds are available from human ovarian epithelial (HOE) cells (<a href="#T1">Table 1</a>). These data reinforce the findings of low selectivity, albeit improved in semisynthetic products 4 and 5.</p> </div> <div class="invivoantimalarialactivityofcycleanine(compound1)." title="sec"> <div class="title" tagx="title" title="title"><i>In vivo</i> antimalarial activity of cycleanine (compound 1).</div> <p>The isolation of the abundant cycleanine (compound 1) in <i>T. subcordata</i> root enabled us to investigate its toxicity in healthy mice and efficacy in murine malaria models after infection with <span class="named-content" title="named-content">Plasmodium berghei</span>. The acute median lethal dose (LD<sub>50</sub>) of cycleanine after 24-h oral administration was determined to be 4.5 g/kg in mice, indicating a good safety profile. The malaria-suppressive activity of cycleanine using two oral doses (25 and 50â€‰mg/kg of body weight/day) following <span class="named-content" title="named-content">P. berghei</span> infection was demonstrated through a significant suppression of parasitemia and an increased mean survival time (MST) compared to those of untreated controls (<a href="#T2">Table 2</a>). In particular, the higher dose (50â€‰mg/kg/day) showed efficacy, both in terms of suppression of parasitemia and in MST, comparable to that for chloroquine at a dose of 5â€‰mg/kg/day. The prophylactic activity of cycleanine, with the same 25 and 50â€‰mg/kg dosing regimen during <span class="named-content" title="named-content">P. berghei</span> infection in mice, was also demonstrated (<a href="#T3">Table 3</a>). At the higher dose (50â€‰mg/kg), cycleanine showed a suppression of parasitemia by 59.0%, only slightly less than that of 76.2% using the prophylactic pyrimethamine control at a dose of 1.2â€‰mg/kg /day.</p> <div class="table-wrap_UNKNOWN" id="T2" orientation="portrait" position="float"><span class="label" tagx="label" title="label">TABLE 2</span> <p>Suppressive activity of cycleanine during early <span class="named-content" title="named-content">Plasmodium berghei</span> infection of mice</p>  <div class="alternatives" title="alternatives"> <table frame="hsides" rules="groups"> <colgroup span="1"> <col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup>  <thead> <tr> <th rowspan="1" colspan="1">Treatment</th> <th rowspan="1" colspan="1">Dose (mg/kg) per day</th> <th rowspan="1" colspan="1">Parasitemia after infection for 96 h (%)<a href="#T2F1"><sup><i>a</i></sup></a></th> <th rowspan="1" colspan="1">Suppression of parasitemia at 96 h (%)<a href="#T2F1"><sup><i>a</i></sup></a></th> <th rowspan="1" colspan="1">MST (days)<a href="#T2F1"><sup><i>a</i></sup></a></th> </tr> </thead> <tbody> <tr> <td rowspan="1" colspan="1">Untreated control</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1">28.3â€‰Â±â€‰1.8</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1">12.5â€‰Â±â€‰0.3</td> </tr> <tr> <td rowspan="2" colspan="1">Cycleanine</td> <td rowspan="1" colspan="1">25</td> <td rowspan="1" colspan="1">15.7â€‰Â±â€‰1.8<a href="#T2F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">44.7</td> <td rowspan="1" colspan="1">24.7â€‰Â±â€‰1.1<a href="#T2F2"><sup><i>b</i></sup></a></td> </tr> <tr> <td rowspan="1" colspan="1">50</td> <td rowspan="1" colspan="1">3.8â€‰Â±â€‰0.7<a href="#T2F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">86.5</td> <td rowspan="1" colspan="1">28.2â€‰Â±â€‰0.9<a href="#T2F2"><sup><i>b</i></sup></a></td> </tr> <tr> <td rowspan="1" colspan="1">Chloroquine</td> <td rowspan="1" colspan="1">5</td> <td rowspan="1" colspan="1">2.0â€‰Â±â€‰0.8<a href="#T2F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">94.0</td> <td rowspan="1" colspan="1">30.0â€‰Â±â€‰0.0<a href="#T2F2"><sup><i>b</i></sup></a></td> </tr> </tbody> </table> <div class="graphic" /> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">a</span><p>Values are expressed as mean Â± standard error of the mean (SEM) (<i>n</i>â€‰=â€‰6 in each group).</p> </div> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">b</span><p>Significant relative to untreated control; <i>P</i>â€‰<div class="â€‰0.001._UNKNOWN" /></p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="T3" orientation="portrait" position="float"><span class="label" tagx="label" title="label">TABLE 3</span> <p>Prophylactic activity of cycleanine in <span class="named-content" title="named-content">Plasmodium berghei</span> infection of mice</p>  <div class="alternatives" title="alternatives"> <table frame="hsides" rules="groups"> <colgroup span="1"> <col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup>  <thead> <tr> <th rowspan="1" colspan="1">Treatment</th> <th rowspan="1" colspan="1">Dose (mg/kg) per day</th> <th rowspan="1" colspan="1">Parasitemia level after infection for 72 h (%)<a href="#T3F1"><sup><i>a</i></sup></a></th> <th rowspan="1" colspan="1">Suppression of parasitemia level after infection for 72 h (%)<a href="#T3F1"><sup><i>a</i></sup></a></th> <th rowspan="1" colspan="1">MST (days)<a href="#T3F1"><sup><i>a</i></sup></a></th> </tr> </thead> <tbody> <tr> <td rowspan="1" colspan="1">Untreated control</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1">20.3â€‰Â±â€‰0.8</td> <td rowspan="1" colspan="1" /> <td rowspan="1" colspan="1">12.7â€‰Â±â€‰0.3</td> </tr> <tr> <td rowspan="2" colspan="1">Cycleanine</td> <td rowspan="1" colspan="1">25</td> <td rowspan="1" colspan="1">11.5â€‰Â±â€‰0.9<a href="#T3F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">43.4</td> <td rowspan="1" colspan="1">23.0â€‰Â±â€‰0.6<a href="#T3F2"><sup><i>b</i></sup></a></td> </tr> <tr> <td rowspan="1" colspan="1">50</td> <td rowspan="1" colspan="1">8.3â€‰Â±â€‰1.0<a href="#T3F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">59.0</td> <td rowspan="1" colspan="1">24.5â€‰Â±â€‰0.6<a href="#T3F2"><sup><i>b</i></sup></a></td> </tr> <tr> <td rowspan="1" colspan="1">Pyrimethamine</td> <td rowspan="1" colspan="1">1.2</td> <td rowspan="1" colspan="1">4.8â€‰Â±â€‰1.1<a href="#T3F2"><sup><i>b</i></sup></a></td> <td rowspan="1" colspan="1">76.2</td> <td rowspan="1" colspan="1">29.8â€‰Â±â€‰0.2<a href="#T3F2"><sup><i>b</i></sup></a></td> </tr> </tbody> </table> <div class="graphic" /> </div> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">a</span><p>Values are expressed as mean Â± SEM (<i>n</i>â€‰=â€‰6 in each group).</p> </div> <div class="fn-type-other" title="other"><span class="label" tagx="label" title="label">b</span><p>Significant relative to control; <i>P</i>â€‰<div class="â€‰0.001._UNKNOWN" /></p> </div> </div> </div> <p>The curative activity and MST of mice after initial <span class="named-content" title="named-content">P. berghei</span> infection and subsequent treatment with cycleanine (compound 1) were determined. After infection of mice for 3 days, cycleanine was administered at both doses of 25 and 50â€‰mg/kg and mice showed decreasing parasitemia in a dose-dependent and time-dependent manner from day 3 to day 7 (<a href="#F2">Fig. 2</a>). The speed of killing of <span class="named-content" title="named-content">P. berghei</span> parasites by chloroquine was much faster than that with cycleanine. Chloroquine reached 0% parasitemia after 5â€‰days, while at that time cycleanine at doses of 25 and 50â€‰mg/kg had remaining levels of 13.3 and 10.5%, respectively (<a href="#F2">Fig. 2</a>). In this curative model, the MST of mice at doses of 25 and 50â€‰mg/kg were 21 and 25â€‰days, respectively, which were significantly longer than that of the control (12â€‰days). However, they were both shorter than that of mice treated with chloroquine (30â€‰days) (see Table S1 in the supplemental material).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FIG 2</span></a></div>   <p>The curative activity of mice treated with cycleanine (compound 1) during established <span class="named-content" title="named-content">P. berghei</span> infection. After infection of mice for 3â€‰days, cycleanine was administered at both doses of 25 and 50â€‰mg/kg, while water and chloroquine at 5â€‰mg/ml were administered as negative and positive controls, respectively. The parasitemia levels were monitored for a total duration of 4â€‰days (from day 3 to day 7).</p>   </div> </div> <div class="invivometabolismofcycleanine." title="sec"> <div class="title" tagx="title" title="title"><i>In vivo</i> metabolism of cycleanine.</div> <p>In order to explore the <i>in vivo</i> metabolism of cycleanine, the plasma and urine of Wistar rats following an oral dose of 120â€‰mg/kg body weight/day over a 24-h period were analyzed for cycleanine metabolites. Samples from urine and plasma were prepared and submitted to high-performance liquid chromatographyâ€"electrospray ionizationâ€"tandem mass spectrometry (HPLC-ESI-MS/MS) analysis. The peak at the retention time of 9.7â€‰min was cycleanine (M0) with the protonated molecular ion <i>m/z</i> of 623.3116 [M+H]<sup>+</sup> (elemental composition C<sub>18</sub>H<sub>43</sub>N<sub>2</sub>O<sub>6</sub>) in the positive ion mode spectrum (<a href="#T4">Table 4</a> and <a href="#F3">Fig. 3</a>; see also Fig. S2 in the supplemental material). In MS/MS, the quasimolecular ion loses a neutral molecular NH<sub>2</sub>CH<sub>3</sub> fragment to generate an ion <i>m/z</i> of 592.2694 also by symmetric cleavage, and breaking C-O and C-C bonds to produce a fragment ion <i>m/z</i> of 312.1594, which can also lose C<sub>2</sub>H<sub>6</sub> to produce a fragment ion <i>m/z</i> of 282.1125. After another C-O and C-C bond cleavage and the subsequent loss of CH<sub>3</sub> and OCH<sub>3</sub>, fragment ions <i>m/z</i> 204.101, 190.0863, and 159.0679 were generated. A fragment ion <i>m/z</i> of 400.1907 was also generated by simultaneous C-O bond cleavage and C-C bond cleavage adjacent to the N atom (<a href="#F3">Fig. 3</a> and Fig. S2).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">FIG 3</span></a></div>   <p>Possible fragmentation pattern of cycleanine. For analysis of fragment ions, see the text.</p>   </div> <div class="table-wrap_UNKNOWN" id="T4" orientation="portrait" position="float"><span class="label" tagx="label" title="label">TABLE 4</span> <p>HPLC-QTOF-MS retention times and mass spectrometric data of cycleanine and its metabolites</p>  <div class="alternatives" title="alternatives"> <table frame="hsides" rules="groups"> <colgroup span="1"> <col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup> <colgroup><col span="1" /></colgroup>  <thead> <tr> <th rowspan="1" colspan="1">Prototype or metabolite</th> <th rowspan="1" colspan="1"><i>t</i> (min)</th> <th rowspan="1" colspan="1">Measured [M+H]<sup>+</sup><i>m/z</i></th> <th rowspan="1" colspan="1">Î"ppm</th> <th rowspan="1" colspan="1">Formula</th> <th rowspan="1" colspan="1">MS/MS fragment(s)</th> <th rowspan="1" colspan="1">Metabolic pathway(s)</th> <th rowspan="1" colspan="1">Plasma</th> <th rowspan="1" colspan="1">Urine</th> </tr> </thead> <tbody> <tr> <td rowspan="1" colspan="1">M0</td> <td rowspan="1" colspan="1">9.9</td> <td rowspan="1" colspan="1">623.3125</td> <td rowspan="1" colspan="1">1.41</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>43</sub>N<sub>2</sub>O<sub>6</sub></td> <td rowspan="1" colspan="1">592.2696, 400.1895, 312.1583, 311.1508, 281.1165, 204.1011, 190.0857, 174.0911, 159.1038</td> <td rowspan="1" colspan="1">Parent</td> <td rowspan="1" colspan="1">+</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M1</td> <td rowspan="1" colspan="1">7.2</td> <td rowspan="1" colspan="1">639.3075</td> <td rowspan="1" colspan="1">1.36</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>43</sub>N<sub>2</sub>O<sub>7</sub></td> <td rowspan="1" colspan="1">592.2472, 416.1838, 310.1422, 220.0964, 204.1046, 190.0815, 175.0955, 157.0901</td> <td rowspan="1" colspan="1">Hydroxylation</td> <td rowspan="1" colspan="1">âˆ’</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M2</td> <td rowspan="1" colspan="1">7.9</td> <td rowspan="1" colspan="1">639.3084</td> <td rowspan="1" colspan="1">2.79</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>43</sub>N<sub>2</sub>O<sub>7</sub></td> <td rowspan="1" colspan="1">621.2977, 416.1864, 400.1917, 327.1469, 312.1361, 220.0964, 206.0780, 175.0988</td> <td rowspan="1" colspan="1">Hydroxylation</td> <td rowspan="1" colspan="1">+</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M3</td> <td rowspan="1" colspan="1">8.1</td> <td rowspan="1" colspan="1">625.2911</td> <td rowspan="1" colspan="1">0.84</td> <td rowspan="1" colspan="1">C<sub>37</sub>H<sub>41</sub>N<sub>2</sub>O<sub>7</sub></td> <td rowspan="1" colspan="1">607.2784, 425.1379, 312.1591, 298.1434, 204.0999, 190.0854, 176.0691, 159.1033</td> <td rowspan="1" colspan="1">Demethylation and hydroxylation</td> <td rowspan="1" colspan="1">âˆ’</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M4</td> <td rowspan="1" colspan="1">9.6</td> <td rowspan="1" colspan="1">609.2956</td> <td rowspan="1" colspan="1">0.96</td> <td rowspan="1" colspan="1">C<sub>37</sub>H<sub>41</sub>N<sub>2</sub>O<sub>6</sub></td> <td rowspan="1" colspan="1">593.2750, 427.1577, 357.1449, 312.1580, 298.1435, 204.1020, 190.0850, 176.0704, 145.0880</td> <td rowspan="1" colspan="1">Demethylation</td> <td rowspan="1" colspan="1">âˆ’</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M5</td> <td rowspan="1" colspan="1">10.1</td> <td rowspan="1" colspan="1">595.2799</td> <td rowspan="1" colspan="1">0.73</td> <td rowspan="1" colspan="1">C<sub>36</sub>H<sub>39</sub>N<sub>2</sub>O<sub>6</sub></td> <td rowspan="1" colspan="1">578.2505, 284.1282, 176.0703, 145.0879</td> <td rowspan="1" colspan="1">Didemethylation</td> <td rowspan="1" colspan="1">âˆ’</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M6</td> <td rowspan="1" colspan="1">10.4</td> <td rowspan="1" colspan="1">637.2918</td> <td rowspan="1" colspan="1">1.12</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>7</sub></td> <td rowspan="1" colspan="1">328.1553, 309.1381, 202.0855, 188.0656, 157.0879</td> <td rowspan="1" colspan="1">Dehydrogenation and hydroxylation</td> <td rowspan="1" colspan="1">+</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M7</td> <td rowspan="1" colspan="1">11.1</td> <td rowspan="1" colspan="1">653.2855</td> <td rowspan="1" colspan="1">0.38</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>8</sub></td> <td rowspan="1" colspan="1">635.2754, 326.1384, 309.1381, 202.0855, 188.0656, 157.0879</td> <td rowspan="1" colspan="1">Dehydrogenation and dihydroxylation</td> <td rowspan="1" colspan="1">+</td> <td rowspan="1" colspan="1">âˆ’</td> </tr> <tr> <td rowspan="1" colspan="1">M8</td> <td rowspan="1" colspan="1">12.1</td> <td rowspan="1" colspan="1">653.2868</td> <td rowspan="1" colspan="1">1.23</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>8</sub></td> <td rowspan="1" colspan="1">592.2459, 310.1420, 293.1154, 281.1163, 269.1169, 204.1031, 190.0884</td> <td rowspan="1" colspan="1">Dehydrogenation and dihydroxylation</td> <td rowspan="1" colspan="1">âˆ’</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M9</td> <td rowspan="1" colspan="1">13</td> <td rowspan="1" colspan="1">653.2856</td> <td rowspan="1" colspan="1">0.27</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>8</sub></td> <td rowspan="1" colspan="1">635.2701, 400.1881, 326.1380, 310.1427, 202.0855, 173.0820, 157.0881</td> <td rowspan="1" colspan="1">Dehydrogenation and dihydroxylation</td> <td rowspan="1" colspan="1">âˆ’</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M10</td> <td rowspan="1" colspan="1">13.4</td> <td rowspan="1" colspan="1">621.2966</td> <td rowspan="1" colspan="1">0.97</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>6</sub></td> <td rowspan="1" colspan="1">591.2467, 400.1893, 398.1739, 312.1572, 310.1435, 204.1013, 202.0860, 190.0863, 188.0725, 159.1028, 157.0883</td> <td rowspan="1" colspan="1">Dehydrogenation</td> <td rowspan="1" colspan="1">+</td> <td rowspan="1" colspan="1">âˆ’</td> </tr> <tr> <td rowspan="1" colspan="1">M11</td> <td rowspan="1" colspan="1">13.6</td> <td rowspan="1" colspan="1">653.2859</td> <td rowspan="1" colspan="1">0.73</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>8</sub></td> <td rowspan="1" colspan="1">413.1375, 324.1595, 309.1345, 281.1158, 204.1015, 159.1021</td> <td rowspan="1" colspan="1">Dehydrogenation and dihydroxylation</td> <td rowspan="1" colspan="1">+</td> <td rowspan="1" colspan="1">+</td> </tr> <tr> <td rowspan="1" colspan="1">M12</td> <td rowspan="1" colspan="1">14.1</td> <td rowspan="1" colspan="1">637.2919</td> <td rowspan="1" colspan="1">1.61</td> <td rowspan="1" colspan="1">C<sub>38</sub>H<sub>41</sub>N<sub>2</sub>O<sub>7</sub></td> <td rowspan="1" colspan="1">594.2486, 414.1684, 326.1381, 312.1237, 281.1159, 218.0824, 204.1013, 190.0874, 173.0830</td> <td rowspan="1" colspan="1">Dehydrogenation and hydroxylation</td> <td rowspan="1" colspan="1">+</td> <td rowspan="1" colspan="1">+</td> </tr> </tbody> </table> <div class="graphic" /> </div> </div> <p>Twelve peaks on LC-MS/MS chromatograms relevant to cycleanine were detected in either urine or plasma samples (<a href="#T4">Table 4</a> and Fig. S3 in the supplemental material). The original form of cycleanine and 11 metabolites were found from the urine of rats, which were presumed to be hydroxylation (M1 and M2), demethylation and hydroxylation (M3), monodemethylation (M4), didemethylation (M5), dehydrogenation and hydroxylation (M6 and M12), and dehydrogenation and dihydroxylation (M7) metabolites, and the isomeric metabolites of M7 (M8, M9, and M11). From the cycleanine-containing plasma of rats, the original form cycleanine (M0) and five metabolites were found, which were presumed to be hydroxylation (M2 and M10), dehydrogenation and hydroxylation (M6 and M12), and dehydrogenation and dihydroxylation (M7) metabolites. Among them, the prototype (M0), hydroxylation (M1), and dehydrogenation and hydroxylation (M6, M12) metabolites were detected in both rat urine and plasma (<a href="#T4">Table 4</a> and supplemental material). Therefore, the metabolic pathway of cycleanine in rats involves hydroxylation, dehydrogenation, and demethylation or their combination, which are the main means of biotransformation of cycleanine to generate a large number of metabolites (M1 to M12) (see Fig. S5 in the supplemental material).</p> </div> </div> <div class="discussion" title="discussion"> <div class="title" tagx="title" title="title">
DISCUSSION</div> <p>Natural products (e.g., artemisinin and quinine) have demonstrated their potential as a source of antimalarial drugs. Previously, a number of BBIQ alkaloids were demonstrated to have <i>in vitro</i> antiplasmodial activities (<a href="#B16">16</a>). Cycleanine had antiplasmodial effects with an IC<sub>50</sub> of 70â€‰nM (<a href="#B16">16</a>) (or 80â€‰nM [<a href="#B17">17</a>]) against <span class="named-content" title="named-content">P. falciparum</span> chloroquine-sensitive clone D6 (or 3D7) and an IC<sub>50</sub> of 4.5â€‰Î¼M against a chloroquine-resistant strain (<a href="#B18">18</a>). Isochondodendrine showed a low IC<sub>50</sub> of 0.2â€‰Î¼M against a chloroquine-resistant strain (<a href="#B18">18</a>, <a href="#B19">19</a>). 2â€²-Norcocsuline also showed potent <i>in vitro</i> antiplasmodial activity, with IC<sub>50</sub> values of 48 and 248â€‰nM against chloroquine-sensitive clone D6 (3D7) and chloroquine-resistant clone W2 (<a href="#B16">16</a>, <a href="#B20">20</a>), respectively (<a href="#T1">Table 1</a>). Our results against <span class="named-content" title="named-content">P. falciparum</span> chloroquine-resistant strain Dd2 also confirmed the <i>in vitro</i> antimalarial activity of these compounds but with slightly higher IC<sub>50</sub> values (<a href="#T1">Table 1</a>) compared to the corresponding values reported in literature. Isochododendrine is a structurally demethylated analogue of cycleanine, and showed a greater potency than cycleanine in the chloroquine-resistant W2 strain and the Dd2 strain in this study (<a href="#T1">Table 1</a>). This indicated that the increase of the hydrophilicity of cycleanine could improve its antiplasmodial activity. The SI values of all three BBIQ alkaloids ranged from 14 to 133 based on the KB or HTC-116 cells and the W2 strain, which were much greater than those based on HOE cells and the Dd2 strain. The discrepancy might be due to the different methodologies (<a href="#B16">16</a>) used to determine IC<sub>50</sub> or the different mammalian cancer cells or <span class="named-content" title="named-content">P. falciparum</span> clones used. The semisynthetic analogues of cycleanine (compounds 4 and 5) produced by chemical modification of cycleanine through introduction of dimethylamino and (mono)alkynylamino groups, respectively, at the C-5 position exhibited increase in antiplasmodial potency and SI relative to cycleanine. The presence of a dimethylamino group in compound 4 could also increase the water solubility of the parent compound as is often found in the modification of other natural products, such as camptothecin (<a href="#B21">21</a>) and thymoquinone (<a href="#B22">22</a>). Compound 5, with a unique aminoalkynyl group, was used as a chemical probe for exploring the mechanism of action (e.g., cellular uptake) of cycleanine in cancer cells using click chemistry (<a href="#B15">15</a>), and can also be utilized for identification of the molecular target of cycleanine in parasite-infected blood cells using a chemoproteomic approach (<a href="#B23">23</a>). By changing the amino substitution groups, additional analogues of cycleanine with a variety of diverse structures can be synthesized for <i>in vitro</i> antiplasmodial evaluation.</p> <p>To further confirm and validate the efficacy of cycleanine (compound 1) <i>in vivo</i>, its safety in healthy mice and efficacy in a murine malaria model was investigated. The LD<sub>50</sub> (4.5 g/kg) of cycleanine indicated that cycleanine has a good safety profile, in agreement with the LD<sub>50</sub> of 1.1 g/kg found previously in mice (<a href="#B24">24</a>). Using suppression, prophylactic, and curative murine malaria models after infection with <span class="named-content" title="named-content">P. berghei</span> (<a href="#B25">25</a>), cycleanine showed a similar or closer effect at an oral dose of 50â€‰mg/kg to their positive controls (chloroquine [5â€‰mg/kg] and pyrimethamine [1.2â€‰mg/kg]). At least, a much higher dose of cycleanine was needed to achieve the effects of these positive controls, indicating a mild efficacy <i>in vivo</i>. However, its low toxicity profile could allow increase of the oral dose (e.g., 100â€‰mg/kg/day), which is expected to improve its efficacy. In the curative model, the slower effect of cycleanine comparing to chloroquine might be due to the metabolism of cycleanine to various metabolites. The <i>in vivo</i> antimalarial activity of cycleanine was consistent with its <i>in vitro</i> antiplasmodial activity. To our knowledge, this is the first demonstration of the <i>in vivo</i> antimalarial efficacy of a BBIQ alkaloid, cycleanine. Overall, three alkaloids (compounds <a href="#B1">1</a> to <a href="#B3">3</a>) of <i>T. subcordata</i> could contribute to the antimalarial effects of this medicinal plant used in Nigeria for the treatment of malaria. BBIQ alkaloids of <span class="named-content" title="named-content">Triclisia gilletii</span> (De Wild) Staner were also reported to be attributed to the <i>in vitro</i> and <i>in vivo</i> antimalarial activity of its plant extract (<a href="#B26">26</a>).</p> <p>Study on the metabolism of drugs can help to further understand their pharmacokinetics, efficacy, and safety (<a href="#B27">27</a>). For example, metabolites of piperaquine were shown to have stronger antiplasmodial activity (<a href="#B28">28</a>). However, there have been only a few <i>in vivo</i> metabolism studies of BBIQ alkaloids. Previously, <i>in vitro</i> metabolites of a BBIQ alkaloid, isoliensinine, from dog hepatic microsomes were identified as 2â€²-<i>N</i>-desmethylisoliensinine, 2-<i>N</i>-desmethyl-isoliensinine, and 2â€²-<i>N</i>-6-<i>O</i>-didesmethylisoliensinine (<a href="#B29">29</a>). The study of the pharmacokinetics and metabolism of another BBIQ alkaloid, neferine, indicated that it was partially converted to liensinine, desmethyl-liensinine, isoliensinine, and desmethyl-isoliensinine by CYP2D6 (<a href="#B30">30</a>). Tetrandrine was found to be initially biotransformed to a quinone methide-derived metabolite mediated by CYP3A enzymes, which was then trapped by a glutathione molecule to form a glutathione conjugate in mice (<a href="#B31">31</a>). Metabolism of isotetrandrine <i>in vitro</i> by the rat hepatic system produced a major metabolite, <i>N</i>-desmethyl isotetrandrine (16%), and three minor oxidized metabolites, oxo-isotetrandrine (7%), hydroxy-isotetrandrine (6%), and oxohydroxy-isotetrandrine (7%), via <i>N</i>-demethylation and isoquinoline ring oxidation (<a href="#B32">32</a>).</p> <p>Our identification of 12 new metabolites of cycleanine in both plasma and urine in rats using LC-MS/MS has indicated that there are various metabolic pathways of cycleanine. These metabolites of cycleanine found in rats are also likely generated in mice after the same route of oral administration, and therefore they could contribute to its <i>in vivo</i> antimalarial efficacy found in the murine malarial model and its toxicity finding in healthy mice. Hydroxylation and demethylation of cycleanine were the common pathways consistent with those found in isoliensinine, neferine, and isotetrandrine described above. Preparation of these metabolites through chemical synthesis (<a href="#B33">33</a>) or <i>in vitro</i> biotransformation using hepatic microsomes and/or P450 enzymes (<a href="#B34">34</a>, <a href="#B35">35</a>) is possible and necessary to evaluate their potency and toxicity. Such information can be used to further guide the chemical design and modification of cycleanine to improve its potency and pharmacokinetics and to increase metabolic stability (<a href="#B36">36</a>). Further work is necessary and ongoing in our laboratory to determine the <i>in vivo</i> antimalarial effects of BBIQ alkaloids (compounds 2 and 3) and semisynthetic derivatives (compounds 4 and 5) and the <i>in vitro</i> and/or <i>in vivo</i> antimalarial activity of the metabolites of cycleanine. Novel active drugs, particularly those with a wide safety margin, are required to help alleviate malaria morbidity and mortality and to contribute to the global control of malaria and infectious diseases.</p> </div> <div class="materials_methods" title="materials|methods"> <div class="title" tagx="title" title="title">
MATERIALS AND METHODS</div> <div class="chemicals." title="sec"> <div class="title" tagx="title" title="title">
Chemicals.</div> <p>Chloroquine and pyrimethamine were sourced from Sigma-Aldrich. Cycleanine (compound 1) (<a href="#B13">13</a>), and two minor alkaloids, isochondodendrine (compound 2) and 2â€²-norcocsuline (compound 3), were isolated from <i>Triclisia subcordata</i> (<a href="#B14">14</a>). Compounds 4 and 5 (<a href="#F1">Fig. 1</a>) were previously prepared from cycleanine (compound 1) (<a href="#B15">15</a>).</p> </div> <div class="invitroantiplasmodialactivity." title="sec"> <div class="title" tagx="title" title="title"><i>In vitro</i> antiplasmodial activity.</div> <p>The evaluation of <i>in vitro</i> antiplasmodial activity of the alkaloids (compounds 1 to 3) and semisynthetic analogues (compounds 4 and 5) were performed on the intraerythrocytic <span class="named-content" title="named-content">P. falciparum</span> Dd2 strain (chloroquine-resistant strain) using a SYBR green1 fluorescence dye assay as described (<a href="#B22">22</a>, <a href="#B37">37</a>, <a href="#B38">38</a>). Compounds 1 to 5 were prepared in dimethyl sulfoxide (DMSO) with no greater than 1% of the total solvent concentration in any assay. Normalized fluorescence signals were measured against controls with 1% DMSO (100% growth) and after exposure to a supralethal concentration (10â€‰Î¼M) of chloroquine (0% growth). Determination of the 50% inhibitory concentration (IC<sub>50</sub>) was performed from a log concentration versus the mean normalized fluorescence signal curve using GraphPad Prism software (v5.0). Each biological replicate consisted of three technical repeats, with three independent biological replicates performed.</p> </div> <div class="evaluationoftheinvivoantimalarialactivityofcycleanine." title="sec"> <div class="title" tagx="title" title="title">
Evaluation of the <i>in vivo</i> antimalarial activity of cycleanine.</div> <p><b>(i) Malaria parasite.</b> Chloroquine-sensitive strains of <span class="named-content" title="named-content">P. berghei</span> were sourced from the National Institute of Medical Research (NIMER), Yaba Lagos, Nigeria, and maintained by subpassage in mice.</p> <p><b>(ii) Parasite inoculation.</b> Each mouse was inoculated intraperitoneally with about 1â€‰Ã—â€‰10<sup>7</sup><span class="named-content" title="named-content">P. berghei</span> parasitized erythrocytes in 0.2â€‰ml of infected blood (5â€‰Ã—â€‰10<sup>7</sup><span class="named-content" title="named-content">P. berghei</span> erythrocytes/ml) according to published procedure (<a href="#B39">39</a>).</p> <p><b>(iii) Experimental animals.</b> Female and male Swiss albino mice (18 to 25 g) were obtained from the University of Uyoâ€™s animal house. Before use, mice were kept in cages and acclimatized for 10â€‰days. All mice were kept in cross-ventilated rooms at room temperature. The care and use of mice were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (1996). This investigation was approved by the University of Uyoâ€™s Animal Ethics Committee.</p> <p><b>(iv) Determination of median lethal dose (LD<sub>50</sub>) of cycleanine.</b> The median lethal dose (LD<sub>50</sub>) of cycleanine was determined using albino mice by the intraperitoneal (i.p.) route (<a href="#B40">40</a>). Different doses of cycleanine (10 to 5,000â€‰mg/kg) were intraperitoneally administered to groups of three mice each. The mice were monitored for manifestation of physical signs of toxicity, including decrease of motor activity, writhing, decrease of body/limb tone, weakness, and death. The number of deaths in each group within 24 h was recorded. The LD<sub>50</sub> value was calculated as the geometrical means of the minimum dose producing 100% mortality and the maximum dose producing 0%.</p> <p><b>(v) Drug administration.</b> Cycleanine, chloroquine, and pyrimethamine were prepared in water and administered orally with the aid of a stainless metallic feeding cannula.</p> <p><b>(vi) Suppressive activity of cycleanine.</b> The schizontocidal activity of cycleanine and chloroquine against early <span class="named-content" title="named-content">P. berghei</span> infection in mice was measured according to an established protocol (<a href="#B25">25</a>, <a href="#B41">41</a>, <a href="#B42">42</a>). On the first day, 20 to 24 mice were infected with the parasite and randomly separated into four groups. The mice in groups 1 and 2 were given 25 and 50â€‰mg/kg of cycleanine, respectively, those in group 3 were given 5â€‰mg/kg of chloroquine (positive control), and those in group 4 were given distilled water (10â€‰ml/kg, negative control) for four consecutive days. Thin films were made from the tail blood on the fifth day. Parasitized erythrocytes were counted in stained films (Giemsa stain) under a microscope. The average suppression of parasitemia (%) was calculated as follows: </p><div class="disp-formula" title="disp-formula"> <div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mfrac_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
average % parasitemia positive control</div> <div class="mi_UNKNOWN">
âˆ’</div> <div class="mtext_UNKNOWN">
average % parasitemia negative control</div> </div> <div class="mrow_UNKNOWN"> <div class="mtext_UNKNOWN">
average % parasitemia negative control</div> </div> </div> <div class="mi_UNKNOWN">
Ã—</div> <div class="mn_UNKNOWN">
100</div> </div></div></div> </div> <p /> <p>The MST (in days) of the mice in each group was determined over a period of 30â€‰days.</p> <p><b>(vii) Prophylactic activity of cycleanine.</b> The prophylactic activity of cycleanine was evaluated using a previously described method (<a href="#B42">42</a>, <a href="#B43">43</a>). The mice were randomly divided into four groups of six mice per group. Groups 1 and 2 were given 25 and 50â€‰mg/kg of cycleanine, respectively, group 3 was given 1.2â€‰mg/kg of pyrimethamine (positive control), and group 4 was given 10â€‰ml/kg of distilled water (negative control). Administration of cycleanine or the drug continued for three consecutive days. On the fourth day, the mice were inoculated with <span class="named-content" title="named-content">P. berghei</span>. The parasitemia level was evaluated by blood smears after 3â€‰days. The survival times (days) of the mice were recorded over a period of 30â€‰days, and MST were calculated.</p> <p><b>(viii) Curative activity of cycleanine.</b> The curative activity of cycleanine was assessed according to a method described previously (<a href="#B42">42</a>, <a href="#B44">44</a>). <span class="named-content" title="named-content">P. berghei</span> was injected intraperitoneally into another 24 mice on the first day. Three days later, the mice were also separated into four groups of six mice per group. Groups 1 and 2 were administered different doses of cycleanine, 25 and 50â€‰mg/kg, respectively, group 3 was given 5â€‰mg/kg chloroquine (positive control), and group 4 was given 10â€‰ml/kg distilled water (negative control). Cycleanine and chloroquine were given once a day for 5â€‰days. Mouse tail blood samples were collected on each day, and Giemsa-stained thin smears were prepared to determine the parasitemia level. The MST of the mice in each group was determined over a period of 30â€‰days.</p> </div> <div class="metabolismofcycleanineinrats." title="sec"> <div class="title" tagx="title" title="title">
Metabolism of cycleanine in rats.</div> <p><b>(i) High-performance liquid chromatographyâ€"quadrupole time-of-flight tandem mass spectrometry.</b> Analysis of cycleanine metabolites was performed through high-performance liquid chromatographyâ€"quadrupole time-of-flight tandem mass spectrometry (HPLC-QTOF-MS/MS) system that consists of an Agilent 1260 HPLC coupled with an 6530 QTOF mass spectrometer with dual Agilent Jet Stream electrospray ionization source (Agilent Technologies, CA). The mass spectra were recorded in positive auto MS/MS mode, and the parameters were set as follows: temperature of drying and sheath gas, 300Â°C and 350Â°C; skimmer, 75 V; capillary voltage, 4,000 V; fragmentor, 110 V; nozzle voltage, 1,000 V; collision energy, 50â€‰eV; pressure of nebulizer, 35 lb/in<sup>2</sup>; and flow rate of the drying and sheath gas, 5 and 11 liter/min, respectively. The QTOF mass spectra were recorded in high-resolution mode. The range of mass-to-charge ratio (<i>m/z</i>) scanning was set between 100 and 1,200. Samples (5 Î¼l) were loaded onto an Agilent Poroshell 120 EC-C<sub>18</sub> column (100â€‰Ã—â€‰2.1â€‰mm, 2.7â€‰Î¼m) at 35Â°C. The mobile phase consisted of water containing 0.1% formic acid (solvent A) and acetonitrile containing 0.1% formic acid (solvent B) at a flow rate of 0.35â€‰ml/min. Gradient separation was achieved by changing the proportion of the solvent B mobile phase as follows: 0 to 2â€‰min, 10% B; 2.1 to 5â€‰min, 18% to 20% B; 30 to 45â€‰min, 70% to 90% B; and 45 to 50â€‰min, 10% B. MassHunter WorkStation software (Agilent Technologies) was utilized for the system operation and data analysis.</p> <p><b>(ii) <i>In vivo</i> experiments.</b><i>In vivo</i> animal experiments were approved by the Animal Ethics Committee of Shanghai Institute of Materia Medica, and performed according to procedures approved by the Institutional Animal Care and Use Committee of Shanghai Institute of Materia Medica, Chinese Academy of Science. Male Wistar rats were obtained from Shanghai SLAC Laboratory Animal Co., Ltd. (Shanghai, China). The rats were given free access to water and a standard diet under controlled humidity (45% to 55%) and temperature (20Â°C to 24Â°C), except in the overnight fasting period before administration of cycleanine. The rats were adapted to the environment for a week.</p> <p>Cycleanine (compound 1) was suspended in 0.4% carboxymethyl cellulose sodium (CMC-Na) and was formulated at 12â€‰mg/ml for intragastric administration to Wistar rats (male, 220â€‰Â±â€‰10 g, fasted for 12â€‰h prior to administration) at a dose of 120â€‰mg/kg body weight. Three rats were used for blood collection through the orbital vein using cannulation at 0, 0.5, 1, 2, 4, 6, 8, 12, and 24 h postdose after anaesthetization with isoflurane. The plasma samples were separated from blood by centrifugation at 12,000â€‰rpm and 4Â°C for 10â€‰min. Another three rats were placed in the metabolism cages, and urine samples were collected into tubes from 0 to 24 h after oral administration of cycleanine. All samples were stored in a âˆ’80Â°C freezer before analysis. Aliquots of 1.2â€‰ml of plasma or urine samples were mixed with 3 times the volume of acetonitrile to precipitate proteins. After centrifugation at 14,000â€‰rpm for 10â€‰min, the supernatant was collected and evaporated under vacuum. The residue was reconstituted in 200 Î¼l methanol, and 5 Î¼l of each sample was injected for HPLC-QTOF-MS/MS analysis.</p> </div> <div class="statisticalanalysis." title="sec"> <div class="title" tagx="title" title="title">
Statistical analysis.</div> <p>Data were expressed as mean Â± standard error of the mean (SEM) for <i>in vivo</i> antimalarial experiments. Data were subjected to GraphPad Prism software analysis. Results were analyzed using one-way analysis of variance (ANOVA) followed by a <i>post hoc</i> Tukey multiple-comparison test. The difference between the mean of the experimental and control groups was considered significant at a <i>P</i> value of &amp;lt;0.05 (ANOVA).</p> </div> <div class="conclusions" title="conclusions"> <div class="title" tagx="title" title="title">
Conclusions.</div> <p>Three BBIQ alkaloids of <i>T. subcordata</i>, cycleanine (compound 1), isochondodendrine (compound 2), and 2â€²-norcocsuline (compound 3) and two semisynthetic analogues (compounds 4 and 5) of cycleanine were demonstrated to exert significant <i>in vitro</i> antiplasmodial activities against <span class="named-content" title="named-content">P. falciparum</span>. Cycleanine (compound 1) was further demonstrated to have safety and efficacy in the treatment of mice infected with <span class="named-content" title="named-content">P. berghei</span>. Cycleanine was transformed to various metabolites in rats after oral delivery. The findings from this study support the use of <i>T. subcordata</i> as an antimalarial agent in traditional medicine. BBIQ alkaloids could be exploited in novel drug development in search of antimalarial agents/drugs that are urgently needed to challenge resistant plasmodium species that currently present a significant threat to human life.</p> </div> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Material</div> <div class="local-data" title="local-data">  <div class="title" tagx="title" title="title">
Supplemental file 1</div>  <div class="media" title="media"><a href="AAC.01995-20-s0001.pdf">LINK</a></div> </div> </div> </div> <div class="back" title="back"> <div class="fn-group" title="fn-group"> <div class="fn-type-supplementary-material" title="supplementary-material"> <p>Supplemental material is available online only.</p> </div> </div> <div class="ack" title="ack"> <div class="title" tagx="title" title="title">
ACKNOWLEDGMENTS</div> <p>This research was funded by Nigerian ETF and NDDC and by BBSRC (HVfCP business interaction voucher).</p> <p>We declare no conflict of interest.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
REFERENCES</div> <li tag="ref"><a name="B1" /><span class="label" tagx="label" title="label">1.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="collab'">collab: WHO</span>. <span class="year" tagx="year" title="year">2019</span><span class="source" tagx="source" title="source">World malaria report 2019</span>. <span class="publisher-name" tagx="publisher-name" title="publisher-name">World Health Organization</span>, <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Geneva, Switzerland</span><a href="https://apps.who.int/iris/rest/bitstreams/1262394/retrieve">https://apps.who.int/iris/rest/bitstreams/1262394/retrieve</a>.</span></li> <li tag="ref"><a name="B2" /><span class="label" tagx="label" title="label">2.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bhatt</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Weiss</span><span class="given-names" tagx="given-names" title="given-names">DJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cameron</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bisanzio</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mappin</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dalrymple</span><span class="given-names" tagx="given-names" title="given-names">U</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Battle</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Moyes</span><span class="given-names" tagx="given-names" title="given-names">CL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Henry</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Eckhoff</span><span class="given-names" tagx="given-names" title="given-names">PA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wenger</span><span class="given-names" tagx="given-names" title="given-names">EA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Briet</span><span class="given-names" tagx="given-names" title="given-names">O</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Penny</span><span class="given-names" tagx="given-names" title="given-names">MA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">TA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bennett</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yukich</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Eisele</span><span class="given-names" tagx="given-names" title="given-names">TP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Griffin</span><span class="given-names" tagx="given-names" title="given-names">JT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fergus</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lynch</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lindgren</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cohen</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Murray</span><span class="given-names" tagx="given-names" title="given-names">CLJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Smith</span><span class="given-names" tagx="given-names" title="given-names">DL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hay</span><span class="given-names" tagx="given-names" title="given-names">SI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cibulskis</span><span class="given-names" tagx="given-names" title="given-names">RE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gething</span><span class="given-names" tagx="given-names" title="given-names">PW</span></span></span><span class="year" tagx="year" title="year">2015</span><span class="mixed-article-title" title="mixed-article-title">The effect of malaria control on <i>Plasmodium falciparum</i> in Africa between 2000 and 2015</span>. <span class="source" tagx="source" title="source">Nature</span><span class="volume" tagx="volume" title="volume">526</span>:<span class="fpage" tagx="fpage" title="fpage">207</span>â€"<span class="lpage" tagx="lpage" title="lpage">211</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/nature15535">10.1038/nature15535</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26375008">26375008</a></span></span></li> <li tag="ref"><a name="B3" /><span class="label" tagx="label" title="label">3.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Spring</span><span class="given-names" tagx="given-names" title="given-names">MD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">JT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Manning</span><span class="given-names" tagx="given-names" title="given-names">JE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vanachayangkul</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Somethy</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bun</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Se</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chann</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ittiverakul</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sia-Ngam</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kuntawunginn</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Arsanok</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Buathong</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chaorattanakawee</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gosi</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ta-Aksorn</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chanarat</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sundrakes</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kong</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Heng</span><span class="given-names" tagx="given-names" title="given-names">TK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nou</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Teja-Isavadharm</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pichyangkul</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Phann</span><span class="given-names" tagx="given-names" title="given-names">ST</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Balasubramanian</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Juliano</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Meshnick</span><span class="given-names" tagx="given-names" title="given-names">SR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Chour</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Prom</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lanteri</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lon</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Saunders</span><span class="given-names" tagx="given-names" title="given-names">DL</span></span></span><span class="year" tagx="year" title="year">2015</span><span class="mixed-article-title" title="mixed-article-title">Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study</span>. <span class="source" tagx="source" title="source">Lancet Infect Dis</span><span class="volume" tagx="volume" title="volume">15</span>:<span class="fpage" tagx="fpage" title="fpage">683</span>â€"<span class="lpage" tagx="lpage" title="lpage">691</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/S1473-3099(15)70049-6">10.1016/S1473-3099(15)70049-6</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/25877962">25877962</a></span></span></li> <li tag="ref"><a name="B4" /><span class="label" tagx="label" title="label">4.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cragg</span><span class="given-names" tagx="given-names" title="given-names">GM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Newman</span><span class="given-names" tagx="given-names" title="given-names">DJ</span></span></span><span class="year" tagx="year" title="year">2013</span><span class="mixed-article-title" title="mixed-article-title">Natural products: a continuing source of novel drug leads</span>. <span class="source" tagx="source" title="source">Biochim Biophys Acta</span><span class="volume" tagx="volume" title="volume">1830</span>:<span class="fpage" tagx="fpage" title="fpage">3670</span>â€"<span class="lpage" tagx="lpage" title="lpage">3695</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bbagen.2013.02.008">10.1016/j.bbagen.2013.02.008</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23428572">23428572</a></span></span></li> <li tag="ref"><a name="B5" /><span class="label" tagx="label" title="label">5.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fernandez-Alvaro</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hong</span><span class="given-names" tagx="given-names" title="given-names">WD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nixon</span><span class="given-names" tagx="given-names" title="given-names">GL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">O'Neill</span><span class="given-names" tagx="given-names" title="given-names">PM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Calderon</span><span class="given-names" tagx="given-names" title="given-names">F</span></span></span><span class="year" tagx="year" title="year">2016</span><span class="mixed-article-title" title="mixed-article-title">Antimalarial chemotherapy: natural product inspired development of preclinical and clinical candidates with diverse mechanisms of action</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="volume" tagx="volume" title="volume">59</span>:<span class="fpage" tagx="fpage" title="fpage">5587</span>â€"<span class="lpage" tagx="lpage" title="lpage">5603</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1021/acs.jmedchem.5b01485">10.1021/acs.jmedchem.5b01485</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26791529">26791529</a></span></span></li> <li tag="ref"><a name="B6" /><span class="label" tagx="label" title="label">6.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bridgford</span><span class="given-names" tagx="given-names" title="given-names">JL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">SC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cobbold</span><span class="given-names" tagx="given-names" title="given-names">SA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pasaje</span><span class="given-names" tagx="given-names" title="given-names">CFA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Herrmann</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gillett</span><span class="given-names" tagx="given-names" title="given-names">DL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dick</span><span class="given-names" tagx="given-names" title="given-names">LR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ralph</span><span class="given-names" tagx="given-names" title="given-names">SA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dogovski</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Spillman</span><span class="given-names" tagx="given-names" title="given-names">NJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tilley</span><span class="given-names" tagx="given-names" title="given-names">L</span></span></span><span class="year" tagx="year" title="year">2018</span><span class="mixed-article-title" title="mixed-article-title">Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome</span>. <span class="source" tagx="source" title="source">Nat Commun</span><span class="volume" tagx="volume" title="volume">9</span>:<span class="fpage" tagx="fpage" title="fpage">3801</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/s41467-018-06221-1">10.1038/s41467-018-06221-1</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30228310">30228310</a></span></span></li> <li tag="ref"><a name="B7" /><span class="label" tagx="label" title="label">7.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span></span><span class="year" tagx="year" title="year">2016</span><span class="mixed-article-title" title="mixed-article-title">Artemisininâ€"a gift from traditional Chinese medicine to the world (Nobel Lecture)</span>. <span class="source" tagx="source" title="source">Angew Chem Int Ed Engl</span><span class="volume" tagx="volume" title="volume">55</span>:<span class="fpage" tagx="fpage" title="fpage">10210</span>â€"<span class="lpage" tagx="lpage" title="lpage">10226</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1002/anie.201601967">10.1002/anie.201601967</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27488942">27488942</a></span></span></li> <li tag="ref"><a name="B8" /><span class="label" tagx="label" title="label">8.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lu</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Culleton</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ramaprasad</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">von Seidlein</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhu</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Menard</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pain</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cao</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="year" tagx="year" title="year">2017</span><span class="mixed-article-title" title="mixed-article-title">Emergence of indigenous artemisinin-resistant <i>Plasmodium falciparum</i> in Africa</span>. <span class="source" tagx="source" title="source">N Engl J Med</span><span class="volume" tagx="volume" title="volume">376</span>:<span class="fpage" tagx="fpage" title="fpage">991</span>â€"<span class="lpage" tagx="lpage" title="lpage">993</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1056/NEJMc1612765">10.1056/NEJMc1612765</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28225668">28225668</a></span></span></li> <li tag="ref"><a name="B9" /><span class="label" tagx="label" title="label">9.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Schiff</span><span class="given-names" tagx="given-names" title="given-names">PL</span></span></span><span class="year" tagx="year" title="year">1997</span><span class="mixed-article-title" title="mixed-article-title">Bisbenzylisoquinoline alkaloids</span>. <span class="source" tagx="source" title="source">J Nat Prod</span><span class="volume" tagx="volume" title="volume">60</span>:<span class="fpage" tagx="fpage" title="fpage">934</span>â€"<span class="lpage" tagx="lpage" title="lpage">953</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1021/np9700174">10.1021/np9700174</a></span>.</span></li> <li tag="ref"><a name="B10" /><span class="label" tagx="label" title="label">10.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Weber</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Opatz</span><span class="given-names" tagx="given-names" title="given-names">T</span></span></span><span class="year" tagx="year" title="year">2019</span><span class="mixed-article-title" title="mixed-article-title">Bisbenzylisoquinoline alkaloids</span>. <span class="source" tagx="source" title="source">Alkaloids Chem Biol</span><span class="volume" tagx="volume" title="volume">81</span>:<span class="fpage" tagx="fpage" title="fpage">1</span>â€"<span class="lpage" tagx="lpage" title="lpage">114</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/bs.alkal.2018.07.001">10.1016/bs.alkal.2018.07.001</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30685048">30685048</a></span></span></li> <li tag="ref"><a name="B11" /><span class="label" tagx="label" title="label">11.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sofowora</span><span class="given-names" tagx="given-names" title="given-names">LA</span></span></span><span class="year" tagx="year" title="year">1982</span><span class="source" tagx="source" title="source">Medicinal plants and traditional medicine in Africa</span>. <span class="publisher-name" tagx="publisher-name" title="publisher-name">John Wiley and Sons Limited</span>, <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Chichester, United Kingdom</span>.</span></li> <li tag="ref"><a name="B12" /><span class="label" tagx="label" title="label">12.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Asuzu</span><span class="given-names" tagx="given-names" title="given-names">IU</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Anaga</span><span class="given-names" tagx="given-names" title="given-names">AO</span></span></span><span class="year" tagx="year" title="year">1996</span><span class="mixed-article-title" title="mixed-article-title">The antiulcer effect of the methanolic extract of <i>Triclisia subcordata</i> leaves in rats</span>. <span class="source" tagx="source" title="source">J Herbs Spices Med Plants</span><span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">45</span>â€"<span class="lpage" tagx="lpage" title="lpage">53</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1300/J044v03n03_07">10.1300/J044v03n03_07</a></span>.</span></li> <li tag="ref"><a name="B13" /><span class="label" tagx="label" title="label">13.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Uche</span><span class="given-names" tagx="given-names" title="given-names">FI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Drijfhout</span><span class="given-names" tagx="given-names" title="given-names">FP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McCullagh</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Richardson</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">WW</span></span></span><span class="year" tagx="year" title="year">2016</span><span class="mixed-article-title" title="mixed-article-title">Cytotoxicity effects and apoptosis induction by bisbenzylisoquinoline alkaloids from <i>Triclisia subcordata</i></span>. <span class="source" tagx="source" title="source">Phytother Res</span><span class="volume" tagx="volume" title="volume">30</span>:<span class="fpage" tagx="fpage" title="fpage">1533</span>â€"<span class="lpage" tagx="lpage" title="lpage">1539</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1002/ptr.5660">10.1002/ptr.5660</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27270992">27270992</a></span></span></li> <li tag="ref"><a name="B14" /><span class="label" tagx="label" title="label">14.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Uche</span><span class="given-names" tagx="given-names" title="given-names">FI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Abed</span><span class="given-names" tagx="given-names" title="given-names">MN</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Abdullah</span><span class="given-names" tagx="given-names" title="given-names">MI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Drijfhout</span><span class="given-names" tagx="given-names" title="given-names">FP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McCullagh</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Claridge</span><span class="given-names" tagx="given-names" title="given-names">TWD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Richardson</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">WW</span></span></span><span class="year" tagx="year" title="year">2017</span><span class="mixed-article-title" title="mixed-article-title">Isochondodendrine and 2â€²-norcocsuline: additional alkaloids from <i>Triclisia subcordata</i>, induced cytotoxicity and apoptosis in ovarian cancer cell lines</span>. <span class="source" tagx="source" title="source">RSC Adv</span><span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">44154</span>â€"<span class="lpage" tagx="lpage" title="lpage">44161</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1039/C7RA08032H">10.1039/C7RA08032H</a></span>.</span></li> <li tag="ref"><a name="B15" /><span class="label" tagx="label" title="label">15.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Uche</span><span class="given-names" tagx="given-names" title="given-names">FI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McCullagh</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Claridge</span><span class="given-names" tagx="given-names" title="given-names">TWD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Richardson</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">WW</span></span></span><span class="year" tagx="year" title="year">2018</span><span class="mixed-article-title" title="mixed-article-title">Synthesis of (aminoalkyl)cycleanine analogues: cytotoxicity, cellular uptake, and apoptosis induction in ovarian cancer cells</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">1652</span>â€"<span class="lpage" tagx="lpage" title="lpage">1656</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmcl.2018.03.038">10.1016/j.bmcl.2018.03.038</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29588214">29588214</a></span></span></li> <li tag="ref"><a name="B16" /><span class="label" tagx="label" title="label">16.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Angerhofer</span><span class="given-names" tagx="given-names" title="given-names">CK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Guinaudeau</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wongpanich</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pezzuto</span><span class="given-names" tagx="given-names" title="given-names">JM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cordell</span><span class="given-names" tagx="given-names" title="given-names">GA</span></span></span><span class="year" tagx="year" title="year">1999</span><span class="mixed-article-title" title="mixed-article-title">Antiplasmodial and cytotoxic activity of natural bisbenzylisoquinoline alkaloids</span>. <span class="source" tagx="source" title="source">J Nat Prod</span><span class="volume" tagx="volume" title="volume">62</span>:<span class="fpage" tagx="fpage" title="fpage">59</span>â€"<span class="lpage" tagx="lpage" title="lpage">66</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1021/np980144f">10.1021/np980144f</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9917283">9917283</a></span></span></li> <li tag="ref"><a name="B17" /><span class="label" tagx="label" title="label">17.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fadaeinasab</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Taha</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fauzi</span><span class="given-names" tagx="given-names" title="given-names">PN</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ali</span><span class="given-names" tagx="given-names" title="given-names">HM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Widyawaruyanti</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span><span class="year" tagx="year" title="year">2015</span><span class="mixed-article-title" title="mixed-article-title">Anti-malarial activity of isoquinoline alkaloids from the stem bark of <i>Actinodaphne macrophylla</i></span>. <span class="source" tagx="source" title="source">Nat Prod Commun</span><span class="volume" tagx="volume" title="volume">10</span>:<span class="fpage" tagx="fpage" title="fpage">1541</span>â€"<span class="lpage" tagx="lpage" title="lpage">1542</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26594753">26594753</a></span></span></li> <li tag="ref"><a name="B18" /><span class="label" tagx="label" title="label">18.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Otshudi</span><span class="given-names" tagx="given-names" title="given-names">AL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Apers</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pieters</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Claeys</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pannecouque</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">De Clercq</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Van Zeebroeck</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lauwers</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Frederich</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Foriers</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span><span class="year" tagx="year" title="year">2005</span><span class="mixed-article-title" title="mixed-article-title">Biologically active bisbenzylisoquinoline alkaloids from the root bark of <i>Epinetrum villosum</i></span>. <span class="source" tagx="source" title="source">J Ethnopharmacol</span><span class="volume" tagx="volume" title="volume">102</span>:<span class="fpage" tagx="fpage" title="fpage">89</span>â€"<span class="lpage" tagx="lpage" title="lpage">94</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jep.2005.05.021">10.1016/j.jep.2005.05.021</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15996841">15996841</a></span></span></li> <li tag="ref"><a name="B19" /><span class="label" tagx="label" title="label">19.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mambu</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Martin</span><span class="given-names" tagx="given-names" title="given-names">MT</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Razafimahefa</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ramanitrahasimbola</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rasoanaivo</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Frappier</span><span class="given-names" tagx="given-names" title="given-names">F</span></span></span><span class="year" tagx="year" title="year">2000</span><span class="mixed-article-title" title="mixed-article-title">Spectral characterisation and antiplasmodial activity of bisbenzylisoquinolines from <i>Isolona ghesquiereina</i></span>. <span class="source" tagx="source" title="source">Planta Med</span><span class="volume" tagx="volume" title="volume">66</span>:<span class="fpage" tagx="fpage" title="fpage">537</span>â€"<span class="lpage" tagx="lpage" title="lpage">540</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1055/s-2000-8610">10.1055/s-2000-8610</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10985080">10985080</a></span></span></li> <li tag="ref"><a name="B20" /><span class="label" tagx="label" title="label">20.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Guinaudeau</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bohlke</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lin</span><span class="given-names" tagx="given-names" title="given-names">LZ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Angerhofer</span><span class="given-names" tagx="given-names" title="given-names">CK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cordell</span><span class="given-names" tagx="given-names" title="given-names">GA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ruangrungsi</span><span class="given-names" tagx="given-names" title="given-names">N</span></span></span><span class="year" tagx="year" title="year">1997</span><span class="mixed-article-title" title="mixed-article-title">(+)-Angchibangkine, a new type of bisbenzylisoquinoline alkaloid, and other dimers from <i>Pachygone dasycarpa</i></span>. <span class="source" tagx="source" title="source">J Nat Prod</span><span class="volume" tagx="volume" title="volume">60</span>:<span class="fpage" tagx="fpage" title="fpage">258</span>â€"<span class="lpage" tagx="lpage" title="lpage">260</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1021/np960568e">10.1021/np960568e</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9157192">9157192</a></span></span></li> <li tag="ref"><a name="B21" /><span class="label" tagx="label" title="label">21.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kingsbury</span><span class="given-names" tagx="given-names" title="given-names">WD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Boehm</span><span class="given-names" tagx="given-names" title="given-names">JC</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jakas</span><span class="given-names" tagx="given-names" title="given-names">DR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Holden</span><span class="given-names" tagx="given-names" title="given-names">KG</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hecht</span><span class="given-names" tagx="given-names" title="given-names">SM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gallagher</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Caranfa</span><span class="given-names" tagx="given-names" title="given-names">MJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McCabe</span><span class="given-names" tagx="given-names" title="given-names">FL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Faucette</span><span class="given-names" tagx="given-names" title="given-names">LF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Johnson</span><span class="given-names" tagx="given-names" title="given-names">RK</span></span></span><span class="year" tagx="year" title="year">1991</span><span class="mixed-article-title" title="mixed-article-title">Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="volume" tagx="volume" title="volume">34</span>:<span class="fpage" tagx="fpage" title="fpage">98</span>â€"<span class="lpage" tagx="lpage" title="lpage">107</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1021/jm00105a017">10.1021/jm00105a017</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/1846923">1846923</a></span></span></li> <li tag="ref"><a name="B22" /><span class="label" tagx="label" title="label">22.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Johnson-Ajinwo</span><span class="given-names" tagx="given-names" title="given-names">OR</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ullah</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mbye</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Richardson</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Horrocks</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">WW</span></span></span><span class="year" tagx="year" title="year">2018</span><span class="mixed-article-title" title="mixed-article-title">The synthesis and evaluation of thymoquinone analogues as anti-ovarian cancer and antimalarial agents</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">1219</span>â€"<span class="lpage" tagx="lpage" title="lpage">1222</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmcl.2018.02.051">10.1016/j.bmcl.2018.02.051</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29519737">29519737</a></span></span></li> <li tag="ref"><a name="B23" /><span class="label" tagx="label" title="label">23.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Drewes</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Knapp</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="year" tagx="year" title="year">2018</span><span class="mixed-article-title" title="mixed-article-title">Chemoproteomics and chemical probes for target discovery</span>. <span class="source" tagx="source" title="source">Trends Biotechnol</span><span class="volume" tagx="volume" title="volume">36</span>:<span class="fpage" tagx="fpage" title="fpage">1275</span>â€"<span class="lpage" tagx="lpage" title="lpage">1286</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.tibtech.2018.06.008">10.1016/j.tibtech.2018.06.008</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30017093">30017093</a></span></span></li> <li tag="ref"><a name="B24" /><span class="label" tagx="label" title="label">24.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wambebe</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gamaniel</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Akah</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kapu</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Samson</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Orisadipe</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Okogun</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="year" tagx="year" title="year">1997</span><span class="mixed-article-title" title="mixed-article-title">Central and uterotonic effects of cycleanine</span>. <span class="source" tagx="source" title="source">Indian J Pharmcol</span><span class="volume" tagx="volume" title="volume">29</span>:<span class="fpage" tagx="fpage" title="fpage">366</span>â€"<span class="lpage" tagx="lpage" title="lpage">372</span>.</span></li> <li tag="ref"><a name="B25" /><span class="label" tagx="label" title="label">25.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Fidock</span><span class="given-names" tagx="given-names" title="given-names">DA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Rosenthal</span><span class="given-names" tagx="given-names" title="given-names">PJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Croft</span><span class="given-names" tagx="given-names" title="given-names">SL</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Brun</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Nwaka</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="year" tagx="year" title="year">2004</span><span class="mixed-article-title" title="mixed-article-title">Antimalarial drug discovery: efficacy models for compound screening</span>. <span class="source" tagx="source" title="source">Nat Rev Drug Discov</span><span class="volume" tagx="volume" title="volume">3</span>:<span class="fpage" tagx="fpage" title="fpage">509</span>â€"<span class="lpage" tagx="lpage" title="lpage">520</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1038/nrd1416">10.1038/nrd1416</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15173840">15173840</a></span></span></li> <li tag="ref"><a name="B26" /><span class="label" tagx="label" title="label">26.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kikueta</span><span class="given-names" tagx="given-names" title="given-names">CM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kambu</span><span class="given-names" tagx="given-names" title="given-names">OK</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mbenza</span><span class="given-names" tagx="given-names" title="given-names">AP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mavinga</span><span class="given-names" tagx="given-names" title="given-names">ST</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mbamu</span><span class="given-names" tagx="given-names" title="given-names">BM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cos</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Maes</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Apers</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Pieters</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cimanga</span><span class="given-names" tagx="given-names" title="given-names">RK</span></span></span><span class="year" tagx="year" title="year">2013</span><span class="mixed-article-title" title="mixed-article-title"><i>In vitro</i> and <i>in vivo</i> antimalarial activity and cytotoxicity of extracts and fractions from the leaves, root-bark and stem-bark of <i>Triclisia gilletii</i></span>. <span class="source" tagx="source" title="source">J Ethnopharmacol</span><span class="volume" tagx="volume" title="volume">149</span>:<span class="fpage" tagx="fpage" title="fpage">438</span>â€"<span class="lpage" tagx="lpage" title="lpage">442</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jep.2013.06.043">10.1016/j.jep.2013.06.043</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23876596">23876596</a></span></span></li> <li tag="ref"><a name="B27" /><span class="label" tagx="label" title="label">27.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yisimayili</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Guo</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xu</span><span class="given-names" tagx="given-names" title="given-names">Z</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Abdulla</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Akber Aisa</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">C</span></span></span><span class="year" tagx="year" title="year">2019</span><span class="mixed-article-title" title="mixed-article-title">Metabolic profiling analysis of corilagin <i>in vivo</i> and <i>in vitro</i> using high-performance liquid chromatography quadrupole time-of-flight mass spectrometry</span>. <span class="source" tagx="source" title="source">J Pharm Biomed Anal</span><span class="volume" tagx="volume" title="volume">165</span>:<span class="fpage" tagx="fpage" title="fpage">251</span>â€"<span class="lpage" tagx="lpage" title="lpage">260</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jpba.2018.12.013">10.1016/j.jpba.2018.12.013</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/30562708">30562708</a></span></span></li> <li tag="ref"><a name="B28" /><span class="label" tagx="label" title="label">28.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yang</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zang</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xing</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="year" tagx="year" title="year">2018</span><span class="mixed-article-title" title="mixed-article-title">Metabolism of piperaquine to its antiplasmodial metabolites and their pharmacokinetic profiles in healthy volunteers</span>. <span class="source" tagx="source" title="source">Antimicrob Agents Chemother</span><span class="volume" tagx="volume" title="volume">62</span>:<span class="comment">e00260-18</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1128/AAC.00260-18">10.1128/AAC.00260-18</a></span>.</span></li> <li tag="ref"><a name="B29" /><span class="label" tagx="label" title="label">29.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">S</span></span></span><span class="year" tagx="year" title="year">2012</span><span class="mixed-article-title" title="mixed-article-title">Identification of three new <i>N</i>-demethylated and <i>O</i>-demethylated bisbenzylisoquinoline alkaloid metabolites of isoliensinine from dog hepatic microsomes</span>. <span class="source" tagx="source" title="source">Molecules</span><span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">11712</span>â€"<span class="lpage" tagx="lpage" title="lpage">11720</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.3390/molecules171011712">10.3390/molecules171011712</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23027371">23027371</a></span></span></li> <li tag="ref"><a name="B30" /><span class="label" tagx="label" title="label">30.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Bai</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhao</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Xiang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="year" tagx="year" title="year">2007</span><span class="mixed-article-title" title="mixed-article-title">Pharmacokinetics and metabolism of neferine in rats after a single oral administration</span>. <span class="source" tagx="source" title="source">Biopharm Drug Dispos</span><span class="volume" tagx="volume" title="volume">28</span>:<span class="fpage" tagx="fpage" title="fpage">361</span>â€"<span class="lpage" tagx="lpage" title="lpage">372</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1002/bdd.556">10.1002/bdd.556</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/17654697">17654697</a></span></span></li> <li tag="ref"><a name="B31" /><span class="label" tagx="label" title="label">31.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tian</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Jiang</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Shen</span><span class="given-names" tagx="given-names" title="given-names">Q</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zeng</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zheng</span><span class="given-names" tagx="given-names" title="given-names">J</span></span></span><span class="year" tagx="year" title="year">2016</span><span class="mixed-article-title" title="mixed-article-title">CYP3A5 mediates bioactivation and cytotoxicity of tetrandrine</span>. <span class="source" tagx="source" title="source">Arch Toxicol</span><span class="volume" tagx="volume" title="volume">90</span>:<span class="fpage" tagx="fpage" title="fpage">1737</span>â€"<span class="lpage" tagx="lpage" title="lpage">1748</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/s00204-015-1584-8">10.1007/s00204-015-1584-8</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26302866">26302866</a></span></span></li> <li tag="ref"><a name="B32" /><span class="label" tagx="label" title="label">32.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">WN</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">McKown</span><span class="given-names" tagx="given-names" title="given-names">LA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Gopaul</span><span class="given-names" tagx="given-names" title="given-names">VS</span></span></span><span class="year" tagx="year" title="year">2004</span><span class="mixed-article-title" title="mixed-article-title"><i>In-vitro</i> metabolism of isotetrandrine, a bisbenzylisoquinoline alkaloid, in rat hepatic S9 fraction by high-performance liquid chromatography-atmospheric pressure ionization mass spectrometry</span>. <span class="source" tagx="source" title="source">J Pharm Pharmacol</span><span class="volume" tagx="volume" title="volume">56</span>:<span class="fpage" tagx="fpage" title="fpage">749</span>â€"<span class="lpage" tagx="lpage" title="lpage">755</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1211/0022357023547">10.1211/0022357023547</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15231040">15231040</a></span></span></li> <li tag="ref"><a name="B33" /><span class="label" tagx="label" title="label">33.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cernak</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Dykstra</span><span class="given-names" tagx="given-names" title="given-names">KD</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Tyagarajan</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vachal</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Krska</span><span class="given-names" tagx="given-names" title="given-names">SW</span></span></span><span class="year" tagx="year" title="year">2016</span><span class="mixed-article-title" title="mixed-article-title">The medicinal chemist's toolbox for late stage functionalization of drug-like molecules</span>. <span class="source" tagx="source" title="source">Chem Soc Rev</span><span class="volume" tagx="volume" title="volume">45</span>:<span class="fpage" tagx="fpage" title="fpage">546</span>â€"<span class="lpage" tagx="lpage" title="lpage">576</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1039/c5cs00628g">10.1039/c5cs00628g</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26507237">26507237</a></span></span></li> <li tag="ref"><a name="B34" /><span class="label" tagx="label" title="label">34.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ren</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Yorke</span><span class="given-names" tagx="given-names" title="given-names">JA</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Taylor</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wong</span><span class="given-names" tagx="given-names" title="given-names">LL</span></span></span><span class="year" tagx="year" title="year">2015</span><span class="mixed-article-title" title="mixed-article-title">Drug oxidation by cytochrome P450BM3: metabolite synthesis and discovering new P450 reaction types</span>. <span class="source" tagx="source" title="source">Chemistry</span><span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">15039</span>â€"<span class="lpage" tagx="lpage" title="lpage">15047</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1002/chem.201502020">10.1002/chem.201502020</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26311271">26311271</a></span></span></li> <li tag="ref"><a name="B35" /><span class="label" tagx="label" title="label">35.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Cusack</span><span class="given-names" tagx="given-names" title="given-names">KP</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Koolman</span><span class="given-names" tagx="given-names" title="given-names">HF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lange</span><span class="given-names" tagx="given-names" title="given-names">UE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Peltier</span><span class="given-names" tagx="given-names" title="given-names">HM</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Piel</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Vasudevan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span><span class="year" tagx="year" title="year">2013</span><span class="mixed-article-title" title="mixed-article-title">Emerging technologies for metabolite generation and structural diversification</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem Lett</span><span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">5471</span>â€"<span class="lpage" tagx="lpage" title="lpage">5483</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.bmcl.2013.08.003">10.1016/j.bmcl.2013.08.003</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23992859">23992859</a></span></span></li> <li tag="ref"><a name="B36" /><span class="label" tagx="label" title="label">36.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Thompson</span><span class="given-names" tagx="given-names" title="given-names">TN</span></span></span><span class="year" tagx="year" title="year">2001</span><span class="mixed-article-title" title="mixed-article-title">Optimization of metabolic stability as a goal of modern drug design</span>. <span class="source" tagx="source" title="source">Med Res Rev</span><span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">412</span>â€"<span class="lpage" tagx="lpage" title="lpage">449</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1002/med.1017">10.1002/med.1017</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11579441">11579441</a></span></span></li> <li tag="ref"><a name="B37" /><span class="label" tagx="label" title="label">37.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Smilkstein</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sriwilaijaroen</span><span class="given-names" tagx="given-names" title="given-names">N</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Kelly</span><span class="given-names" tagx="given-names" title="given-names">JX</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Wilairat</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Riscoe</span><span class="given-names" tagx="given-names" title="given-names">M</span></span></span><span class="year" tagx="year" title="year">2004</span><span class="mixed-article-title" title="mixed-article-title">Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening</span>. <span class="source" tagx="source" title="source">Antimicrob Agents Chemother</span><span class="volume" tagx="volume" title="volume">48</span>:<span class="fpage" tagx="fpage" title="fpage">1803</span>â€"<span class="lpage" tagx="lpage" title="lpage">1806</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1128/aac.48.5.1803-1806.2004">10.1128/aac.48.5.1803-1806.2004</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15105138">15105138</a></span></span></li> <li tag="ref"><a name="B38" /><span class="label" tagx="label" title="label">38.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Aldulaimi</span><span class="given-names" tagx="given-names" title="given-names">O</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Uche</span><span class="given-names" tagx="given-names" title="given-names">FI</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Hameed</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mbye</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ullah</span><span class="given-names" tagx="given-names" title="given-names">I</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Drijfhout</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Claridge</span><span class="given-names" tagx="given-names" title="given-names">TDW</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Horrocks</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">WW</span></span></span><span class="year" tagx="year" title="year">2017</span><span class="mixed-article-title" title="mixed-article-title">A characterization of the antimalarial activity of the bark of <i>Cylicodiscus gabunensis</i> Harms</span>. <span class="source" tagx="source" title="source">J Ethnopharmacol</span><span class="volume" tagx="volume" title="volume">198</span>:<span class="fpage" tagx="fpage" title="fpage">221</span>â€"<span class="lpage" tagx="lpage" title="lpage">225</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/j.jep.2017.01.014">10.1016/j.jep.2017.01.014</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28089716">28089716</a></span></span></li> <li tag="ref"><a name="B39" /><span class="label" tagx="label" title="label">39.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Odetola</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Basir</span><span class="given-names" tagx="given-names" title="given-names">O</span></span></span><span class="year" tagx="year" title="year">1980</span><span class="chapter-title" tagx="chapter-title" title="chapter-title">Evaluation of antimalarial properties of some Nigerian medicinal plants</span>, p <span class="fpage" tagx="fpage" title="fpage">275</span>â€"<span class="lpage" tagx="lpage" title="lpage">283</span>. <i>In</i><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sofowora</span><span class="given-names" tagx="given-names" title="given-names">A</span></span></span> (ed), <span class="source" tagx="source" title="source">Proceedings of African Bioscience Network, Federal Ministry of Science and Technology</span>. <span class="comment">University of Ife Organized Workshop</span><span class="publisher-name" tagx="publisher-name" title="publisher-name">Nigerian Society of Pharmacology and Drug Research and Production Unit</span>, <span class="publisher-loc" tagx="publisher-loc" title="publisher-loc">Ife, Nigeria</span>.</span></li> <li tag="ref"><a name="B40" /><span class="label" tagx="label" title="label">40.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Lorke</span><span class="given-names" tagx="given-names" title="given-names">D</span></span></span><span class="year" tagx="year" title="year">1983</span><span class="mixed-article-title" title="mixed-article-title">A new approach to practical acute toxicity testing</span>. <span class="source" tagx="source" title="source">Arch Toxicol</span><span class="volume" tagx="volume" title="volume">54</span>:<span class="fpage" tagx="fpage" title="fpage">275</span>â€"<span class="lpage" tagx="lpage" title="lpage">287</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1007/BF01234480">10.1007/BF01234480</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/6667118">6667118</a></span></span></li> <li tag="ref"><a name="B41" /><span class="label" tagx="label" title="label">41.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Knight</span><span class="given-names" tagx="given-names" title="given-names">DJ</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Peters</span><span class="given-names" tagx="given-names" title="given-names">W</span></span></span><span class="year" tagx="year" title="year">1980</span><span class="mixed-article-title" title="mixed-article-title">The antimalarial activity of <i>N</i>-benzyloxydihydrotriazines. I. The activity of clociguanil (BRL 50216) against rodent malaria, and studies on its mode of action</span>. <span class="source" tagx="source" title="source">Ann Trop Med Parasitol</span><span class="volume" tagx="volume" title="volume">74</span>:<span class="fpage" tagx="fpage" title="fpage">393</span>â€"<span class="lpage" tagx="lpage" title="lpage">404</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1080/00034983.1980.11687360">10.1080/00034983.1980.11687360</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/7006531">7006531</a></span></span></li> <li tag="ref"><a name="B42" /><span class="label" tagx="label" title="label">42.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Okokon</span><span class="given-names" tagx="given-names" title="given-names">JE</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Antia</span><span class="given-names" tagx="given-names" title="given-names">BS</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Mohanakrishnan</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Sahal</span><span class="given-names" tagx="given-names" title="given-names">D</span></span></span><span class="year" tagx="year" title="year">2017</span><span class="mixed-article-title" title="mixed-article-title">Antimalarial and antiplasmodial activity of husk extract and fractions of <i>Zea mays</i></span>. <span class="source" tagx="source" title="source">Pharm Biol</span><span class="volume" tagx="volume" title="volume">55</span>:<span class="fpage" tagx="fpage" title="fpage">1394</span>â€"<span class="lpage" tagx="lpage" title="lpage">1400</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1080/13880209.2017.1302966">10.1080/13880209.2017.1302966</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28320254">28320254</a></span></span></li> <li tag="ref"><a name="B43" /><span class="label" tagx="label" title="label">43.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Peters</span><span class="given-names" tagx="given-names" title="given-names">W</span></span></span><span class="year" tagx="year" title="year">1965</span><span class="mixed-article-title" title="mixed-article-title">Drug resistance in <i>Plasmodium berghei</i> Vincke and Lips, 1948. I. Chloroquine resistance</span>. <span class="source" tagx="source" title="source">Exp Parasitol</span><span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">80</span>â€"<span class="lpage" tagx="lpage" title="lpage">89</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1016/0014-4894(65)90012-3">10.1016/0014-4894(65)90012-3</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/5843289">5843289</a></span></span></li> <li tag="ref"><a name="B44" /><span class="label" tagx="label" title="label">44.</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Ryley</span><span class="given-names" tagx="given-names" title="given-names">JF</span></span>, <span class="string-name" title="string-name"><span class="surname" tagx="surname" title="surname">Peters</span><span class="given-names" tagx="given-names" title="given-names">W</span></span></span><span class="year" tagx="year" title="year">1970</span><span class="mixed-article-title" title="mixed-article-title">The antimalarial activity of some quinolone esters</span>. <span class="source" tagx="source" title="source">Ann Trop Med Parasitol</span><span class="volume" tagx="volume" title="volume">64</span>:<span class="fpage" tagx="fpage" title="fpage">209</span>â€"<span class="lpage" tagx="lpage" title="lpage">222</span>. doi:<span class="pub-id"><a href="https://dx.doi.org/10.1080/00034983.1970.11686683">10.1080/00034983.1970.11686683</a></span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/4992592">4992592</a></span></span></li> </ul> </div> </div>  </body></html>